Skip to content Skip to footer
Imetelstat: Benefits, Reviews, Info, Side Effects!
Rx Details
Imetelstat
GRN163L, Telomerase inhibitor
Imetelstat
Prescription
Drug
Drugs
Not FDA Approved
Inhibition of telomerase activity, potential treatment for certain types of cancer, possible extension of telomeres in specific conditions, potential to slow down cancer cell proliferation, may enhance the effectiveness of other cancer therapies.
Anemia, Cough, Diarrhea, Dizziness, Fatigue, Headache, Liver Function Test Abnormalities, Nausea, Neutropenia, Thrombocytopenia
Imetelstat is an investigational drug primarily studied for the treatment of certain types of blood cancers, such as myelofibrosis and myelodysplastic syndromes. The dosage of imetelstat can vary depending on the specific clinical trial or treatment protocol. In clinical studies, imetelstat is often administered intravenously, and the dosage can range from 2 mg/kg to 9.4 mg/kg, typically given every three to four weeks. However, it’s important to note that the exact dosage and schedule should be determined by a healthcare professional based on the individual patient’s condition and response to treatment. Always refer to the specific clinical trial protocol or consult with a healthcare provider for precise dosing information.
Myelofibrosis, essential thrombocythemia, myelodysplastic syndromes
Safety profile of Imetelstat is still being evaluated.
No Interactions Reported
$13,000 for a 4 mL vial of 7.5 mg/mL solution.

A Synopsis of

Imetelstat

Imetelstat is a promising drug that has shown great potential in the treatment of various types of cancer. It belongs to a class of drugs known as telomerase inhibitors, which work by targeting the enzyme telomerase that is overexpressed in many cancer cells. By inhibiting telomerase, Imetelstat can effectively halt the growth and spread of cancer cells.

Clinical trials have demonstrated the efficacy of Imetelstat in treating certain types of blood cancers, such as myelofibrosis and myelodysplastic syndromes. Patients who have not responded well to traditional treatments have shown significant improvements in their condition when treated with Imetelstat. Additionally, Imetelstat has shown promise in treating solid tumors, such as lung and breast cancer.

As with any medication, there are potential side effects associated with Imetelstat. These may include fatigue, nausea, and low blood cell counts. It is important for patients to discuss these potential side effects with their healthcare provider before starting treatment with Imetelstat.

Overall, Imetelstat represents a new and innovative approach to cancer treatment. Its ability to target telomerase, a key enzyme in cancer cell growth, makes it a valuable addition to the arsenal of cancer-fighting drugs. As research continues to uncover the full potential of Imetelstat, we are hopeful that it will continue to improve outcomes for patients battling cancer.

RxDb Legal Disclaimer

The information provided on RxDB.net is for informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional, such as a doctor or pharmacist, for any questions or concerns regarding your health, medications, or medical conditions. Reliance on any information provided on this website is solely at your own risk. RxDB.net does not provide medical or pharmaceutical services and is not liable for any decisions made based on the information contained herein.

PAGE LAST UPDATED

Health Education Through Aggregation

Sign up for the Rx Database Newsletter!
Menu
Questions?

Website By Foxco © 2025. All rights reserved.

0
Would love your thoughts, please comment.x
()
x
en_USEN